Idexx Laboratories is poised for recurring revenue growth following the launch of its InVue product, further strengthening its position in the veterinary diagnostic lab market. The company benefits from increased pet ownership and owners’ willingness to spend more on pet care. This aligns with a December 2025 report highlighting the InVue Cellular Analyzer’s potential impact.
Idexx Launch of InVue Provides Path to Recurring Revenue
Idexx Laboratories is poised for recurring revenue growth following the launch of its InVue product, further strengthening its position in the veterinary diagnostic lab market. The company benefits from increased pet ownership and owners’ willingness to spend more on pet care. This aligns with a December 2025 report highlighting the InVue Cellular Analyzer’s potential impact.